| Treffer 1 - 5 |  |
| ART-NR | PRODUKT | HERSTELLER | MENGE | PREIS |
| LKT-L1817.1 |
CAS: 75706-12-6 Pyrimidine biosynthesis inhibitor  Leflunomide is a pyrimidine biosynthesis inhibitor. It is an established disease-modifying antirheumatic drug. It has been approved for treatment of rheumatoid arthritis (RA) and may also be useful in treating patients with Felty´s syndrome. It is sug ... mehr MW: 270 D Purity: >98% |
LKT |
1 g |
278 €
 |
| LKT-L1817.100 |
CAS: 75706-12-6 Pyrimidine biosynthesis inhibitor Leflunomide is a pyrimidine biosynthesis inhibitor. It is an established disease-modifying antirheumatic drug. It has been approved for treatment of rheumatoid arthritis (RA) and may also be useful in treating patients with Felty´s syndrome. It is sug ... mehr MW: 270 D Purity: >98% |
LKT |
100 mg |
56 €
|
| LKT-L1817.500 |
CAS: 75706-12-6 Pyrimidine biosynthesis inhibitor Leflunomide is a pyrimidine biosynthesis inhibitor. It is an established disease-modifying antirheumatic drug. It has been approved for treatment of rheumatoid arthritis (RA) and may also be useful in treating patients with Felty´s syndrome. It is sug ... mehr MW: 270 D Purity: >98% |
LKT |
500 mg |
184 €
|
LKT-ST103.100 |
Drug discovery The compounds that are included are Ginkgolide A, Ginkgolide B, Ginkgolide C, Ginkgolide AB, Leflunomide, Lisinopril, Daunorubicin HCl, Epirubicin HCl. The standard volume is 100 µl per well (1 mM compound). |
LKT |
100 µl |
186 €
|
|
SIH-368-50MG |
CAS: 75706-12-6 Immunosupressant Leflunomide is an Immuno-suppressant, it inhibits de novo synthesis of pyrimidine nucleotides and the activity of the protein kinase. It is a part of the known 'disease-modifying anti-rheumatic drugs' (DMARD). It has been suggested that leflunomide modula ... mehr MW: 270 D Formula: C12H9F3N2O2 Purity: >98% |
StressMarq |
50 mg |
57 €
|
|
|
Datenbank vom 24.05.2013, 14:30 Uhr Die Preise verstehen sich exkl. Versandkosten, eventuell anfallender Kühlmittelpauschale sowie der jeweils geltenden Mehrwertsteuer |
1 |
|
Warenkorb